Literature DB >> 27930623

Letter From the Editor: Fellowship interviews and more.

Bruce D Cheson1.   

Abstract

Mesh：

Year:  2016        PMID： 27930623

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

1.  A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.

Authors:  Yasuhito Terui; Shinya Rai; Koji Izutsu; Motoko Yamaguchi; Jun Takizawa; Junya Kuroda; Takayuki Ishikawa; Koji Kato; Youko Suehiro; Noriko Fukuhara; Ken Ohmine; Hideki Goto; Kazuhito Yamamoto; Nobuhiro Kanemura; Yasunori Ueda; Kenichi Ishizawa; Kyoya Kumagai; Atsuko Kawasaki; Tomohisa Saito; Misato Hashizume; Hirohiko Shibayama
Journal:  Cancer Sci       Date:  2021-06-04       Impact factor: 6.716
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.